中电控股
00002 · HK
I'm noticing the technical indicators are mostly unavailable, and the news headlines don't seem to relate to CLP Holdings at all-they're about insulin and other unrelated topics. I need to flag this mismatch in the report and stick to the facts provided.# 00002 Research Preview
| Metric | Reading | Confidence |
|---|---|---|
| Price | HKD 77.55 | High (quote) |
| Daily move | -0.70% | High (quote) |
| Day range | 77.20 / 78.30 | High (quote) |
| Volume | 2,406,706 | High (quote) |
| Strategy score | 50/100 (Hold) | Medium |
| Trend | Consolidation | Medium |
| RSI | N/A | Low (missing) |
| MACD | N/A | Low (missing) |
| Support | N/A | Low (missing) |
| Resistance | N/A | Low (missing) |
| 30-session range position | N/A | Low (missing) |
| Data confidence (technical) | Low | Low |
| Indicator | Reading | State |
|---|---|---|
| MA (5/10/20/60) | N/A | Insufficient moving-average data |
| RSI (14/6) | N/A | RSI14 unavailable |
| MACD (line/signal/hist) | N/A | MACD unavailable |
| KDJ (K/D/J) | N/A | KDJ unavailable |
| Bollinger Bands (U/M/L) | N/A | Bollinger position unavailable |
| ATR14 / ATR14% | N/A | Unavailable |
| OBV / OBV slope | N/A | OBV unavailable |
| CCI20 | N/A | CCI unavailable |
- Confirmed: Nothing in the momentum, trend, or volume indicator set is confirmed. Every indicator input returned N/A.
- Conflicted: No conflict can be assessed because there are no populated readings to compare.
- Missing: The entire panel is missing - MA structure, RSI, MACD, KDJ, Bollinger, ATR, OBV, and CCI. The only observable technical facts are the raw quote (price, day range, volume) and the strategy score. The five score sub-components (MA交叉, MACD背离, RSI极值, 布林带, 量价关系) each read 50/100 Hold with the explicit note 数据不足 (insufficient data), so the neutral score reflects absent data rather than a balanced signal. No custom indicators were supplied.
| Axis | Reading | Source | Confidence |
|---|---|---|---|
| PE | 20.72 | AkShare Eastmoney HK financial indicators | Medium |
| PB | 2.02 | AkShare Eastmoney HK financial indicators | Medium |
| PEG proxy | 1.15 | StockKit scenario model | Medium |
| Fair-value range | Bear HKD 75.03 / Base HKD 103.18 / Bull HKD 129.64 | StockKit DCF scenario model | Medium |
| Base fair-value gap | +33.1% | StockKit DCF scenario model | Medium |
| 5Y growth forecast | Bear +10.00% / Base +18.00% / Bull +24.00% | StockKit scenario model | Medium |
| Operating income | HKD 79.50B | AkShare Eastmoney HK financial indicators | Medium |
| Holder profit | HKD 9.45B | AkShare Eastmoney HK financial indicators | Medium |
| EPS TTM | 3.74 | AkShare Eastmoney HK financial indicators | Medium |
| Book value per share | 38.47 | AkShare Eastmoney HK financial indicators | Medium |
| Gross margin | +33.54% | AkShare Eastmoney HK financial indicators | Medium |
| Net margin | +13.12% | AkShare Eastmoney HK financial indicators | Medium |
The PEG proxy (1.15), fair-value range, base fair-value gap (+33.1%), and 5Y growth forecast are StockKit scenario model outputs computed from public financial history - they are internally computed forecasts, not analyst consensus targets. PE of 20.72 against EPS TTM of 3.74, and PB of 2.02 against book value per share of 38.47, are consistent with the HKD 77.55 quote. Margins (gross +33.54%, net +13.12%) and holder profit of HKD 9.45B on operating income of HKD 79.50B are drawn from the AkShare report period of 2025-12-31. EV/EBITDA, market cap, dividend yield, and the 52-week range were not supplied and are omitted.
| Date | Headline | Source | Status |
|---|---|---|---|
| 2026-07-28 | Certain Types of Insulin are in short supply nationwide | Freerepublic.com | Confirmed headline |
| 2026-07-21 | Show HN: Ave, a behavioral classification standard for agentic AI | Github.com | Confirmed headline |
| 2026-07-12 | Karnataka builder failed to give promised amenities for 6 years; RERA intervenes | Livemint | Confirmed headline |
| 2026-07-11 | Builder failed to provide promised amenities for 6 years; Karnataka RERA steps in | The Times of India | Confirmed headline |
| 2026-07-08 | Shoppers Drug Mart and Obesity Canada Announce New Collaboration | GlobeNewswire | Confirmed headline |
Confirmed vs missing: Five headlines are present, but none references 00002 / 中电控股 or its operations. On their face they cover insulin supply, an AI classification project, Indian real-estate regulation, and a Canadian obesity-care collaboration. Because no supplied data links these items to the company, their relevance as company catalysts is low, and I will not infer any connection. Genuine company-specific catalysts - earnings dates, dividends, regulatory or operational events - are missing from the dataset. Confidence in this section as a company catalyst timeline is therefore low.
| Source | Status | Reading | Confidence |
|---|---|---|---|
| NewsAPI headline coverage | 5 headlines | Freerepublic.com x1, Github.com x1, Livemint x1 | Medium |
| Social sentiment | Not connected | No social sentiment conclusion is drawn | Low |
No provider-level sentiment score was supplied for this symbol, and social sentiment is marked Not connected. In line with that, no Reddit, X, StockTwits, or local-forum reading is generated. The only sentiment input is raw headline coverage, which - as noted in Section 5 - does not clearly map to the company, so it provides limited directional signal.
| Scenario | Trigger condition | What would confirm it | What would invalidate it |
|---|---|---|---|
| Base | Price holds within recent consolidation and above the StockKit Bear watch level of HKD 75.03; strategy trend stays "consolidation" | Sustained trade toward the StockKit Base fair value of HKD 103.18 (base gap +33.1%), supported by the +18.00% base 5Y growth forecast | Decisive break below HKD 75.03, or restored technical data showing a confirmed downtrend |
| Upside | Move above the current 78.30 day high with follow-through, alongside improving fundamentals versus the 2025-12-31 report period | Progress toward the StockKit Bull fair value of HKD 129.64 on the +24.00% bull growth path | Failure to clear/hold above 78.30; margins or holder profit (HKD 9.45B) deteriorating in a later report |
| Downside | Break and close below the StockKit Bear watch level of HKD 75.03 | Continuation lower with the Bear +10.00% growth path becoming the operative case | Reclaim of HKD 75.03 and re-entry into the consolidation band |
Watch levels above are observation points derived from the quote and StockKit scenario model, not instructions. The absence of populated support/resistance and MA data lowers confidence in these boundaries.
| Risk | Evidence | Trigger | Monitoring action |
|---|---|---|---|
| Technical blind spot | All indicators (MA/RSI/MACD/KDJ/Bollinger/ATR/OBV/CCI) N/A; score components flagged 数据不足 | Any sharp move with no indicator context | Wait for restored technical feed before acting on momentum/trend signals |
| Neutral score is data-driven, not conviction-driven | Overall score 50/100 Hold, trend consolidation | Score changes once data repopulates | Re-check score and sub-components when indicators return |
| Valuation gap may not close | StockKit base gap +33.1% is a model output, not consensus | Fundamentals diverge from +18.00% base growth assumption | Compare next AkShare report against the 2025-12-31 baseline |
| Catalyst vacuum | Five supplied headlines show no clear link to 00002 | No company-specific news arrives | Track for genuine company filings, earnings, and dividend events |
| No sentiment signal | Social sentiment Not connected; no provider score | Reliance on unrelated headlines | Treat sentiment as unavailable until a connected source is supplied |
| Thin session liquidity read | Volume 2,406,706 with no 20-session average for comparison | Volume spike without baseline context | Obtain 20-session average volume before judging volume/price behavior |
1. HKD 75.03 StockKit Bear watch level - monitor for a hold or a decisive close below. 2. The 77.20-78.30 intraday band - watch for a break above 78.30 or below 77.20. 3. Restoration of technical indicators (MA, RSI, MACD, KDJ, Bollinger, ATR, OBV, CCI) so the panel can be assessed. 4. Any change in the strategy score away from 50/100 Hold or the consolidation trend. 5. Volume versus a 20-session average once that baseline becomes available. 6. Arrival of genuine company-specific news for 00002 (filings, dividends, operational updates), distinct from the currently unrelated headlines. 7. Connection of a sentiment provider so a Medium/High-confidence sentiment reading can replace the current gap.
This brief is a public-facing research preview built only from the supplied dataset. It is not personalized investment advice and makes no promise of returns. The technical panel, support/resistance, sentiment score, and news relevance are low confidence due to missing or unrelated data; valuation and fundamentals are Medium confidence from AkShare Eastmoney HK indicators (report period 2025-12-31). PEG, fair-value range, base gap, and growth forecasts are StockKit scenario model outputs, not analyst consensus. All watch levels are observation points, not instructions.
数据不足
数据不足
数据不足
数据不足
数据不足
Certain Types of Insulin are in short supply nationwide
Freerepublic.com · 2026-07-28
Show HN: Ave, a behavioral classification standard for agentic AI
Github.com · 2026-07-21
Karnataka builder failed to give promised amenities for 6 years; RERA intervenes: What you can do if it happens to you
Livemint · 2026-07-12
Builder failed to provide promised amenities for 6 years; Karnataka RERA steps in and issues 90-day deadline to give promised amenities
The Times of India · 2026-07-11
Shoppers Drug Mart and Obesity Canada Announce New Collaboration to Help Expand Access to Obesity Care for Canadians
GlobeNewswire · 2026-07-08
Research boundary
StockKit organizes market data and model output for research workflows. It does not provide personalized advice or trade instructions. Verify important information with primary sources before any investment decision.